Institutional investors purchased a net $6.4 million shares of ALIM during the quarter ended June 2017 and now own 50.27% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PALO ALTO INVESTORS LLC Bought 9.0 Million shares of Alimera Sciences Inc
LIVINGSTON GROUP ASSET MANAGEMEN... Sold 100.00 shares of Alimera Sciences Inc